Is Hong Kong planning to expand the scope of confidential IPO applications? The Hong Kong Stock Exchange responds: "We will announce relevant developments to the market in due course."
Recently, there have been reports that Hong Kong is considering expanding the scope of confidential IPO applications, allowing a wider range of companies to submit initial public offering (IPO) applications confidentially in order to consolidate Hong Kong’s position as a leading global listing destination. In response, a spokesperson for the Hong Kong Exchanges and Clearing Limited (HKEX) stated that HKEX is committed to optimizing market infrastructure and listing mechanisms to ensure they remain up to date. Over the past few years, HKEX has introduced several significant reforms, including new rules in 2018 allowing companies with dual-class share structures to list and permitting biotech companies without revenue to list, as well as the launch of the Specialized Technology Enterprise listing mechanism in 2023. HKEX will continue to work closely with the Hong Kong Securities and Futures Commission (SFC) to further enhance the exchange’s competitiveness through multifaceted efforts, and will announce relevant progress to the market in due course. Additionally, the SFC told reporters that it will continue to collaborate closely with HKEX to explore measures to further enhance the competitiveness of Hong Kong’s listing market, ensuring that Hong Kong remains the preferred listing destination for high-quality companies. (Securities Times)
Source:富途快讯 · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
24H Trending
-
1
What Is JGN? Analysis of the JGN (Sword Saint Coin) Project’s Positioning, Features, and Value
-
2
Analysis: The State Street Healthcare ETF (XLV) has an expense ratio of 0.08% and a diversified portfolio, while the Invesco Biotechnology ETF (PBE) has an expense ratio of 0.58% and focuses on small-cap stocks; PBE is up 10.2% year-to-date, outperforming XLV.
-
3
Analysis Compares Healthcare ETFs: Invesco Nasdaq Biotech ETF (IBBQ) Saw 45.5% One-Year Return, Outperforming State Street Healthcare Select Sector SPDR ETF (XLV)
-
4
Iran-linked exchange Shelbit allegedly sent $676 million to Binance in sanctions-evasion operation, Reuters reports
-
5
Analysis: Vanguard Small-Cap Growth ETF (VBK) up 21% YTD 2026, Outperforming Large-Cap Growth ETF (VONG) at 0.3% YTD
-
6
Berkshire Hathaway Holds Record $400B Cash, Net Seller for 3+ Years; "Buffett Indicator" Hits All-Time High Suggesting Stocks Are Expensive
-
7
What Is POLA? Background and Investment Risk Analysis of the Pola On Base Project
-
8
Claiming Social Security benefits at age 62 instead of 67 can reduce monthly payments by 30%, potentially costing average retirees $150,000 over 20 years.
-
9
What Is DuckChain (DUCK)? An Analysis of Its Future Prospects
-
10
Analysis: Roundhill N-100 0DTE Covered Call ETF (QDTE) Payouts May Include Return of Capital, Trailing Nasdaq-100 Performance
Markets Today
Recommended Reading





